3
Participants
Start Date
April 30, 1996
Primary Completion Date
January 31, 2001
topotecan hydrochloride
Clinique de Pediatrie, Geneva
State University of New York - Upstate Medical University, Syracuse
Johns Hopkins Oncology Center, Baltimore
Duke Comprehensive Cancer Center, Durham
Memorial Mission Hospital, Asheville
Emory University Hospital - Atlanta, Atlanta
University of Alabama Comprehensive Cancer Center, Birmingham
Children's Hospital of Michigan, Detroit
Midwest Children's Cancer Center, Milwaukee
Children's Memorial Hospital, Chicago, Chicago
Washington University School of Medicine, St Louis
Via Christi Regional Medical Center, Wichita
MBCCOP - LSU Medical Center, New Orleans
University of Arkansas for Medical Sciences, Little Rock
Medical City Dallas Hospital, Dallas
Baylor College of Medicine, Houston
Lucile Packard Children's Hospital at Stanford, Palo Alto
University of California San Diego Cancer Center, La Jolla
Shands Hospital and Clinics, University of Florida, Gainesville
University of Kansas Medical Center, Kansas City
Boston Floating Hospital Infants and Children, Boston
Dana-Farber Cancer Institute, Boston
Hackensack University Medical Center, Hackensack
Roswell Park Cancer Institute, Buffalo
Saint Jude Children's Research Hospital, Memphis
Simmons Cancer Center - Dallas, Dallas
San Antonio Military Pediatric Cancer and Blood Disorders Center, Lackland Air Force Base
University of Texas Health Science Center at San Antonio, San Antonio
Montreal Children's Hospital, Montreal
Hopital Sainte Justine, Montreal
University of Puerto Rico School of Medicine Medical Sciences Campus, San Juan
National Cancer Institute (NCI)
NIH